{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Achievements, Investigations in Gynecologic Oncology Explored
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on recent treatment advances for gynecologic cancer.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify findings regarding the pathogenesis of gynecologic cancers and recommendations for prevention of some of these cancers.
- Evaluate therapeutic and pharmacologic advances in the treatment of gynecologic cancers.
Disclosures
The authors and all staff in a position to control the content of this CME/CNE activity have disclosed that they and their spouses/life partners (if any) have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.
Price:
$17.95
Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT0616
Published: Jun 2016
Expires: 12/31/2026
Sources:
Oncology Times
Required Passing Score: 7/10 (70%)
Specialties:
Oncology,
Women's Health